PREVALENCE OF ANTIBODIES TO HERPES-SIMPLEX VIRUS IN PREGNANT-WOMEN IN STOCKHOLM IN 1969, 1983 AND 1989 - IMPLICATIONS FOR STD EPIDEMIOLOGY

被引:96
作者
FORSGREN, M
SKOOG, E
JEANSSON, S
OLOFSSON, S
GIESECKE, J
机构
[1] Virus Department, Central Microbiological Laboratory, Stockholm County Council, Stockholm
[2] Department of Virology, Institute of Medical Microbiology, University of Göteborg, Göteborg
[3] Department of Epidemiology and Population Sciences, London School of Hygiene & Tropical Medicine, London
关键词
HERPES SIMPLEX VIRUS; SEXUAL BEHAVIOR; PREGNANCY; STD;
D O I
10.1177/095646249400500207
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Prevalence of antibody to herpes simplex virus types 1 and 2 was assessed in consecutive serum samples from a total of 3700 women pregnant in 1969, 1983, or 1989 from the same catchment area in Stockholm. There was little change in seroprevalence of antibody to herpes simplex type 1 in the 3 groups, but age-adjusted herpes simplex virus type 2 antibody prevalence was 19, 33, and 33% respectively. Increase in type 2 seropositivity with age was slight and similar in 1969 and 1989, but steep in 1983, indicating a shift in sexual behaviour. However, rising prevalence in women will be mirrored by rising prevalence in their male partners. The increase from 1969 to 1989 will thus partly be due to higher risk of infection per partner, and cannot be taken as direct evidence of increased rate of partner change during this 20-year period.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 15 条
  • [1] Nahmias A.J., Lee F.K., Beckman-Nahmias S., Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world, Scand J Inject Dis, pp. 19-36, (1990)
  • [2] Stavraky K.M., Rawls W.E., Chiavetta J., Donner A.P., Wanklin J.M., Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2, Am J Epidemiol, 118, pp. 109-121, (1983)
  • [3] Breinig M.K., Kingsley L.A., Armstrong J.A., Freeman D.J., Ho M., Epidemiology of genital herpes in Pittsburgh: Serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections, J Infect Dis, 162, pp. 299-305, (1990)
  • [4] Kjaer S.K., Engholm G., Teisen C., Et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: A population-based study, Am J Epidemiol, 131, pp. 669-682, (1990)
  • [5] Johnson R.E., Nahmias A.J., Magder L.S., Lee F.K., Brooks C.A., Snowden C.B., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, N Engl J Med, 321, pp. 7-12, (1989)
  • [6] Ades A.E., Peckham C.B., Dale G.E., Best J.M., Jeansson S., Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection, J Epidemiol Commun Health, 43, pp. 53-60, (1989)
  • [7] Koutsky L.A., Ashley R.L., Holmes K.K., Et al., The frequency of unrecognized type 2 herpes simplex virus infection among women, Sex Transm Dis, 17, pp. 90-94, (1990)
  • [8] Lowhagen G.B., Jansen E., Nordenfeit E., Lycke E., Epidemiology of genital herpes infections in Sweden, Acta Derm Venereol Stockh, 70, pp. 330-334, (1990)
  • [9] Forsgren M., Genital herpes simplex virus infection and incidence of neonatal disease in Sweden, Scand J Infect Dis, pp. 37-41, (1990)
  • [10] Jeansson S., Forsgren M., Svennerholm B., Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay, J Clin Microbiol, 19, pp. 1160-1166, (1983)